SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 65 filers reported holding SUTRO BIOPHARMA INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,861 | -85.1% | 20,421 | -80.1% | 0.00% | -83.3% |
| Q2 2023 | $476,848 | -43.6% | 102,548 | -43.9% | 0.01% | -47.8% |
| Q1 2023 | $844,832 | -32.2% | 182,864 | +18.6% | 0.02% | -34.3% |
| Q4 2022 | $1,245,984 | +288.2% | 154,206 | +166.5% | 0.04% | +218.2% |
| Q3 2022 | $321,000 | +53.6% | 57,869 | +312.1% | 0.01% | -15.4% |
| Q4 2021 | $209,000 | -17.4% | 14,041 | -56.9% | 0.01% | -27.8% |
| Q2 2020 | $253,000 | +125.9% | 32,601 | +219.1% | 0.02% | +157.1% |
| Q4 2019 | $112,000 | – | 10,215 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $34,466,000 | 16.86% |
| Samsara BioCapital, LLC | 1,675,579 | $31,652,000 | 4.97% |
| First Light Asset Management, LLC | 2,191,439 | $41,396,000 | 2.73% |
| FRAZIER MANAGEMENT LLC | 1,468,663 | $27,743,000 | 2.22% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,306,000 | 2.13% |
| Opaleye Management Inc. | 537,800 | $10,159,000 | 1.90% |
| Parkman Healthcare Partners LLC | 163,389 | $3,086,000 | 0.78% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,233,695 | $42,194,000 | 0.71% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 139,331 | $2,629,000 | 0.63% |
| BVF INC/IL | 826,825 | $15,619,000 | 0.61% |